18 August 2021: OIA response | Funding and dispensing data for oxybutynin, tolterodine and solifenacin

18 August 2021

Dear [name and contact details withheld]

Request for information

Thank you for your request dated 29 July 2021 under the Official Information Act 1982 (OIA) for information relating to medicines used for overactive bladder and urinary incontinence: oxybutynin, tolterodine and solifenacin.

You requested we provide information to you per the excel template included in your request.

Please find attached with this response letter, a copy of the excel template with data populated per the tables provided.

We trust that this information answers your queries. We are making our information more freely available, so we now publish selected OIA responses (excluding personal details) on our website. Please get in touch with us if you have any questions about this.

Yours sincerely 

Rachel Read
Manager, Policy and Government Services